Fundraising FoxBlossomHill Therapeutics
San Diego, US · Founded 2020 · Delaware corporation · 2 known investors
Find your way into BlossomHill Therapeutics
Each arrow is one introduction. Sign up to fill in the first one.
344 people can intro you to YISHAN
Ask Sheila Gujrathi, MD to introduce you to YISHAN LI
You →Sheila · together at BlossomHill Therapeutics, Inc. →YISHAN
Sign up to find every way you can get introduced to BlossomHill Therapeutics
- Your email: who you already know at BlossomHill Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the BlossomHill Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Small molecule drug discovery company focused on oncology and autoimmune disorders.
Founders & leadership
BlossomHill Therapeutics was founded in 2020 by Jingrong Jean Cui.
JJ
Jingrong Jean CuiFounder
YL
YISHAN LIExecutiveYishan Li holds a Ph.D. in biochemistry from Ohio State University and an M.B.A. from UC Berkeley's Haas School of Business; he co-founded Turning Point Therapeutics (acquired by Bristol Myers Squibb for $4.1 billion in 2022) where he served as Chairman and CEO, and later co-founded BlossomHill Therapeutics, a small molecule drug discovery company focused on oncology and autoimmune disorders that completed an IPO on NASDAQ in 2026.
LP
Li Peter YishanNamed on SEC filing
Board
GL
GEORGE LEEBoard director
CG
CARL GORDONBoard director
SA
SUNDEEP AGRAWALBoard director
BC
BIHUA CHENBoard director
TS
TIMOTHY STUBBSBoard director
Investors · 2
OrbiMedlisted by OrbiMedNew York · $1M – $75M
How we know: OrbiMed's portfolio page · a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$245.8M disclosed across 4 rounds · 2020–2025
▶$84.2MraisedDec 2025 · 47 investors · PharmaceuticalsRule 506(b)
▶$84.2MraisedDec 2025 · 47 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- GEORGE LEEDirector
- CARL GORDONDirector
- YISHAN LIExecutive Officer, Director
- SUNDEEP AGRAWALDirector
- BIHUA CHENDirector
- TIMOTHY STUBBSDirector
- JINGRONG JEAN CUIExecutive Officer, Director
- Offering amount
- $84.2M
- Amount sold
- $84.2M
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$88.6MraisedJan 2024 · 44 investors · PharmaceuticalsRule 506(b)
▶$88.6MraisedJan 2024 · 44 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Sundeep AgrawalDirector
- Jingrong Jean CuiExecutive Officer, Director
- Bihua ChenDirector
- George LeeDirector
- Carl GordonDirector
- Yishan LiExecutive Officer, Director
- Hongbo LuDirector
- Offering amount
- $100M
- Amount sold
- $88.6M
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$71MraisedMar 2021 · 27 investors · PharmaceuticalsRule 506(b)
▶$71MraisedMar 2021 · 27 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- George LeeDirector
- Li Peter YishanExecutive Officer, Director
- Bihua ChenDirector
- Carl GordonDirector
- Jingrong Jean CuiExecutive Officer, Director
- Offering amount
- $71M
- Amount sold
- $71M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$2MraisedJan 2021 · 3 investors · PharmaceuticalsRule 506(b)
▶$2MraisedJan 2021 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Jingrong Jean CuiExecutive Officer, Director
- Li Peter YishanExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $2M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does BlossomHill Therapeutics do?
- Small molecule drug discovery company focused on oncology and autoimmune disorders.
- Who founded BlossomHill Therapeutics?
- BlossomHill Therapeutics was founded by Jingrong Jean Cui in 2020.
- Who are BlossomHill Therapeutics's investors?
- BlossomHill Therapeutics's investors include OrbiMed, Lilly Asia Ventures.
- How much funding has BlossomHill Therapeutics raised?
- BlossomHill Therapeutics has disclosed $245.8M raised across 4 rounds.
- Where is BlossomHill Therapeutics headquartered?
- BlossomHill Therapeutics is headquartered in San Diego, US.